1-154000946-C-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The ENST00000368559.8(NUP210L):c.5296G>T(p.Ala1766Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000124 in 1,613,928 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
ENST00000368559.8 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
NUP210L | NM_207308.3 | c.5296G>T | p.Ala1766Ser | missense_variant | 37/40 | ENST00000368559.8 | NP_997191.2 | |
NUP210L | XM_011510122.2 | c.5164G>T | p.Ala1722Ser | missense_variant | 36/39 | XP_011508424.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
NUP210L | ENST00000368559.8 | c.5296G>T | p.Ala1766Ser | missense_variant | 37/40 | 5 | NM_207308.3 | ENSP00000357547 | P2 | |
NUP210L | ENST00000368553.5 | c.1730-5766G>T | intron_variant | 1 | ENSP00000357541 | A2 | ||||
NUP210L | ENST00000271854.3 | c.4931-5766G>T | intron_variant | 5 | ENSP00000271854 | A2 |
Frequencies
GnomAD3 genomes AF: 0.00000658 AC: 1AN: 152074Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.00000801 AC: 2AN: 249556Hom.: 0 AF XY: 0.00000739 AC XY: 1AN XY: 135396
GnomAD4 exome AF: 6.84e-7 AC: 1AN: 1461854Hom.: 0 Cov.: 31 AF XY: 0.00000138 AC XY: 1AN XY: 727236
GnomAD4 genome AF: 0.00000658 AC: 1AN: 152074Hom.: 0 Cov.: 32 AF XY: 0.00 AC XY: 0AN XY: 74278
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Nov 07, 2022 | The c.5296G>T (p.A1766S) alteration is located in exon 37 (coding exon 37) of the NUP210L gene. This alteration results from a G to T substitution at nucleotide position 5296, causing the alanine (A) at amino acid position 1766 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at